All Photos(1)
Documents
I5385
Monoclonal Anti-Human IgG1 (Fab specific) G1m(f) antibody produced in mouse
clone SG-16, ascites fluid
All Photos(1)
MDL number:
NACRES:
NA.46
Pricing and availability is not currently available.
Quality Level
biological source
mouse
antibody form
ascites fluid
antibody product type
secondary antibodies
clone
SG-16, monoclonal
contains
15 mM sodium azide
application(s)
indirect ELISA: 1:5,000
isotype
IgG1
conjugate
unconjugated
shipped in
dry ice
storage temp.
−20°C
Related Categories
General description
Monoclonal Anti-Human IgG1 (mouse IgG1isotype) is derived from the hybridoma produced by the fusion of mouse myeloma cells and splenocytes from an immunized mouse. Human IgGs are glycoprotein antibodies that contain two equivalent light chains and a pair of identical heavy chains. IgGs have four distinct isoforms, ranging from IgG1 to IgG4.
Immunogen
Purified human IgG
Application
Monoclonal anti-Human IgG1 may be used for the identification of human IgG1 subclass by means of various immunoassays. It can be used in direct hemagglutination (HA) and hemagglutination inhibition (HAI) assays, immunofluorometric assay (IFMA) and detection of cytoplasmic IgG. Monoclonal anti-human IgG1 has been used in enzyme linked immunosorbent assay (ELISA).
Biochem/physiol Actions
Human IgGs regulate immunological responses to allergy and pathogenic infections. IgGs have also been implicated in complement fixation and autoimmune disorders This product clone recognizes the G1m(f) allotype and has been established as a useful human IgG1 specificity standard by the WHO/IUIS study.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Hazard Codes
Xn
Risk Statement
21/22
Safety Statement
36/37-60
RIDADR
NONH for all modes of transport
WGK Germany
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificate of Analysis
Certificate of Origin
Recurrence of monoclonal gammopathy associated with donor-derived myelodysplastic syndrome after cord blood stem cell transplantation
Yamazaki R, et al.
Experimental Hematology, 39(12), 1119-1123 (2011)
Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantation
Yamazaki R, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation, 19(7), 1013-1020 (2013)
Andreas Lossius et al.
Annals of clinical and translational neurology, 4(10), 756-761 (2017-10-20)
Immunoglobulin gamma (IgG) heavy chain genes are associated with susceptibility to multiple sclerosis (MS) and IgG levels in the cerebrospinal fluid (CSF). However, how these variants are implicated in disease mechanisms remains unknown. Here, we show that proliferating plasmablasts expressing...
Rie Yamazaki et al.
Experimental hematology, 39(12), 1119-1123 (2011-09-14)
Myelodysplastic syndrome (MDS) is known to be associated with functional abnormalities of B cells, including hypergammaglobulinemia and monoclonal gammopathy (MG). However, the pathogenesis of these immunological disorders has not been clarified. We report a patient who developed donor-derived MDS followed...
Papadea C. and Check IJ.
Critical Reviews in Clinical Laboratory Sciences, 27, 27-58 (1989)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical ServiceSupport
Customer SupportContact UsFAQSafety Data Sheets (SDS)Certificates (COA/COO)Quality & RegulatoryCalculators & AppsWebinarsSocial Media
MilliporeSigma
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.
© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.
Reproduction of any materials from the site is strictly forbidden without permission.